PS

Priyanka Sharma

Active Director Director DIN 08111181
DIN 08111181 First appointment Apr 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Priyanka Sharma

Data last updated:

Priyanka Sharma is a Director at Iriska Pharmaceuticals Private Limited (since 2018). The company operates in Healthcare. Iriska Pharmaceuticals Private Limited reported revenue of ₹3.03 Cr (FY 2025).

DIN 08111181
Primary Designation Director
Industry Healthcare
First Appointment 16 Apr 2018
Oldest Company Age 8 yrs
Largest company Iriska Pharmaceuticals Private Limited · ₹3.03 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Apr 20182018₹3.03 Cr (FY 2025)Active

Board colleagues of Priyanka Sharma

NameDINCompanyDesignation
Rahul Yadav08111180Iriska Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Iriska Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priyanka Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Sharma

Priyanka Sharma currently holds 1 directorship: Iriska Pharmaceuticals Private Limited (Director, since 16 Apr 2018, revenue ₹3.03 Cr (FY 2025)).

Priyanka Sharma was first appointed on 16 Apr 2018 as Director at Iriska Pharmaceuticals Private Limited.

The current boards of Priyanka Sharma's companies include Rahul Yadav (Iriska Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available